Profil
Stephen A.
Ross worked as Senior Vice President-Sales & Marketing at Jazz Pharmaceuticals (EUSA Pharma USA), Inc. in 2007-2008, Chief Commercial Officer & EVP at Ikaria, Inc., Vice President-Specialty Business Units at GSK Plc in 2007, and General Manager at GlaxoSmithKline (Ireland) Ltd.
He completed his undergraduate degree at Brigham Young University and earned an MBA from The Wharton School of the University of Pennsylvania.
Anciens postes connus de Stephen A. Ross
| Sociétés | Poste | Fin |
|---|---|---|
Jazz Pharmaceuticals (EUSA Pharma USA), Inc.
 Jazz Pharmaceuticals (EUSA Pharma USA), Inc. BiotechnologyHealth Technology Jazz Pharmaceuticals (EUSA Pharma USA), Inc. develops and markets biopharmaceutical products. The company was founded on November 7, 1980 and is headquartered in Princeton, NJ. | Sales & Marketing | 01/08/2008 |
| GSK PLC | Corporate Officer/Principal | 01/06/2007 |
GlaxoSmithKline (Ireland) Ltd.
 GlaxoSmithKline (Ireland) Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline (Ireland) Ltd. is a company based in Dublin, Ireland. | Corporate Officer/Principal | - |
| IKARIA, INC. | Corporate Officer/Principal | - |
Formation de Stephen A. Ross
| Brigham Young University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GSK PLC | Health Technology |
| Entreprise privées | 3 |
|---|---|
Jazz Pharmaceuticals (EUSA Pharma USA), Inc.
Jazz Pharmaceuticals (EUSA Pharma USA), Inc. BiotechnologyHealth Technology Jazz Pharmaceuticals (EUSA Pharma USA), Inc. develops and markets biopharmaceutical products. The company was founded on November 7, 1980 and is headquartered in Princeton, NJ. | Health Technology |
Ikaria, Inc.
 Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ. | Health Technology |
GlaxoSmithKline (Ireland) Ltd.
GlaxoSmithKline (Ireland) Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline (Ireland) Ltd. is a company based in Dublin, Ireland. | Health Technology |
